Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Vignot

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Bulletin Du Cancer|May 16, 2015
[Abiraterone: Overall survival benefit and subsidiary issues]Stéphane Vignot
Bulletin Du Cancer|May 16, 2015
[Adjuvant chemotherapy for stage I lung cancer in the elderly]Stéphane Vignot
Bulletin Du Cancer|December 10, 2024
[Selpercatinib in advanced solid tumors with RET fusion, in the absence of therapeutic alternatives]Clara Helal, Stéphane Vignot
Bulletin Du Cancer|August 19, 2015
[The frontage and the other headlines]Stéphane Vignot, Nicolas Magné
Bulletin Du Cancer|November 25, 2015
[Non-small cell lung cancer: Remarkable developments]Stéphane Vignot, Marie Wislez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
A step in the journey of denosumab from bone-targeted therapy to seed- and soil-targeted therapyStéphane Vignot, David Khayat
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and non small-cell lung cancer]Stéphane Vignot, Benjamin Besse
Bulletin Du Cancer|September 30, 2019
[New prescription procedures for authorisations for temporary use: A key step for access to innovation]Stéphane Vignot, Elodie Chapel
Bulletin Du Cancer|June 11, 2025
[Repotrectinib in advanced cancers with NTRK fusion after progression or not on a first TRK inhibitor]Léo Ventelou, Stéphane Vignot
Bulletin Du Cancer|June 30, 2015
[Molecular targeted therapies and cytotoxics: Friends or foes?]Stéphane Vignot, Gérard Zalcman
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Bulletin Du Cancer|May 16, 2015
[Abiraterone: Overall survival benefit and subsidiary issues]Stéphane Vignot
Bulletin Du Cancer|May 16, 2015
[Adjuvant chemotherapy for stage I lung cancer in the elderly]Stéphane Vignot
Bulletin Du Cancer|December 10, 2024
[Selpercatinib in advanced solid tumors with RET fusion, in the absence of therapeutic alternatives]Clara Helal, Stéphane Vignot
Bulletin Du Cancer|August 19, 2015
[The frontage and the other headlines]Stéphane Vignot, Nicolas Magné
Bulletin Du Cancer|November 25, 2015
[Non-small cell lung cancer: Remarkable developments]Stéphane Vignot, Marie Wislez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
A step in the journey of denosumab from bone-targeted therapy to seed- and soil-targeted therapyStéphane Vignot, David Khayat
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and non small-cell lung cancer]Stéphane Vignot, Benjamin Besse
Bulletin Du Cancer|September 30, 2019
[New prescription procedures for authorisations for temporary use: A key step for access to innovation]Stéphane Vignot, Elodie Chapel
Bulletin Du Cancer|June 11, 2025
[Repotrectinib in advanced cancers with NTRK fusion after progression or not on a first TRK inhibitor]Léo Ventelou, Stéphane Vignot
Bulletin Du Cancer|June 30, 2015
[Molecular targeted therapies and cytotoxics: Friends or foes?]Stéphane Vignot, Gérard Zalcman
Pageof 12